The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer
- PMID: 23093252
- DOI: 10.1158/2159-8290.CD-12-0432
The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer
Abstract
Miyamoto and colleagues present data that prostate-specific antigen/prostate-specific membrane antigen (PSA/PSMA)-based measurements of androgen receptor (AR) signaling in circulating tumor cells (CTC) enable real-time quantitative monitoring of intratumoral AR signaling. This finding indicates that measuring AR signaling within CTCs may help to guide therapy in metastatic prostate cancer and highlights the use of CTCs as liquid biopsy.
©2012 AACR.
Comment on
-
Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer.Cancer Discov. 2012 Nov;2(11):995-1003. doi: 10.1158/2159-8290.CD-12-0222. Epub 2012 Oct 23. Cancer Discov. 2012. PMID: 23093251 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
